Significant Ownership of Ho Chi Sing
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Ho Chi Sing focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Ho Chi Sing - Ho Chi Sing
- Manager location
- Hong Kong
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Ho Chi Sing with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Ho Chi Sing
Significant Ownership of Ho Chi Sing
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CASI | CASI Pharmaceuticals, Inc. | Ordinary Shares, par value US$0.0001 per share | 4.8% | $754,405 | 992,638 | 0% | Zhou Quan | 30 Sep 2025 | |
| PONY | Pony AI Inc. | Class A ordinary shares, par value US$0.0005 per share | 4.3% | $343,510,641 | -$66,897,472 | 15,273,928 | -16% | IDG China Venture Capital Fund IV L.P. | 30 Sep 2025 |
Schedules 13D/G Reported by Ho Chi Sing:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.